Phlexglobal to Host Summer Seminar Series Focused on Trial Master File Health

Leading Authority in TMF Technology and Services for pharmaceutical companies to host four complimentary events on new EMA regulations and reaching the TMF Health Zone

TMF Healthzone graphic (1)

To achieve and maintain ongoing TMF health and inspection readiness – the “TMF Health Zone” – requires experienced people trained on effective processes using the right technology. 

News

 

Amersham, UK; Malvern, PA. — June 20, 2019 — Phlexglobal today announced an exciting series of complimentary seminars aimed at helping pharmaceutical companies meet regulatory guidelines and achieve optimum TMF Health.

United Kingdom Lunch and Learn Events:
What Rules & Regulations are Doing for TMF Health 
Phlexglobal will host two Lunch and Learn events to present information about the new EMA Guideline on the Content, Management and Archiving of the TMF and how this may impact life sciences companies. There will be time for attendees to ask questions and discuss specific points in an informal setting as well as networking with industry colleagues. Lunch will be provided.

Cambridge, United Kingdom: 31 July 
Details available at http://www.phlexglobal.com/CambridgeUK2019 
Oxford, United Kingdom: 7 August 
Details available at http://www.phlexglobal.com/OxfordUK2019
Digital Brain Header Large Brain Right

It's time to raise your standard 

CONTACT PHLEXGLOBAL TODAY
 
Contact Us

Latest News

TMF Standard Model V1 Transition: Preparing for Change

When my Trial Master File (TMF) career began, the TMF Reference Model did not exist. Every customer had a different way of organising the contents of their TMF, and it was rarely interpreted

A Day in the Life: TMF Team – What Type of TMF Resource Do You Actually Need?

Building the Right TMF Team for Inspection Readiness, Scalability and Growth As clinical trials become more complex, many Sponsors and CROs find themselves asking the same question: Do we need more

A Day in the Life: TMF Program Lead - The Hidden Cost of Managing Studies One at a Time

Why portfolio-level TMF oversight is becoming a necessity, not a luxury. The Problem With Thinking Study-by-Study Clinical trials do not happen in isolation. Sponsors and CROs are running multiple